4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester

4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester Basic information
Product Name:4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester
Synonyms:4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester
CAS:3029365-95-2
MF:C32H29IN4O4S2
MW:724.63
EINECS:
Product Categories:
Mol File:3029365-95-2.mol
4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester Structure
4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester Chemical Properties
density 1.561±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
pka8.88±0.70(predicted)
form Solid
color Light yellow to yellow
Safety Information
MSDS Information
4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester Usage And Synthesis
UsesPROTAC Bcl-xL ligand-1 is a ligand for Bcl-xL that can be used in the synthesis of PROTACs[1].
References[1] Chun-Wa Chung, et al. Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. ACS Chem Biol. 2020 Sep 18;15(9):2316-2323. DOI:10.1021/acschembio.0c00266
4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester Preparation Products And Raw materials
Tag:4-Thiazolecarboxylic acid, 2-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-(4-iodophenoxy)propyl]-, ethyl ester(3029365-95-2) Related Product Information
3,6-Dichloro-benzo[b]thiophene-2-carboxylic acid AZD 5991 (AZD5991) DT2216 Ibrutinib 2-Butanol, 1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-, (2R,3R)-rel- ABT-263